For Patients | FrançaisFr

Physician Survey

All Questions are Mandatory!

  1. 1.
    How do you access Mylan Pharmaceuticals ULC’s Clinical Education and Awareness Resource(CLEARMD)?
  2. 2.
    The patient must have ___ negative pregnancy tests before starting ClarusMD therapy with the first pregnancy test conducted at initial assessment.
  3. 3.
    The patient must have a second serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL with a negative result, performed in a licensed laboratory, within 11 days prior to initiating therapy.
  4. 4.
    Pregnancy tests must be repeated ___ for pregnancy detection during ClarusMD treatment.
  5. 5.
    Pregnancy tests must be repeated at one month after discontinuation of treatment.
  6. 6.
    The dates and results of the pregnancy tests should be documented.
  7. 7.
    Do you feel that you are knowledgeable in the use of retinoids systemically?
  8. 8.
    Do you understand the risk of teratogenicity in females of child bearing age?
  9. 9.
    Are you experienced in counselling young adults?
  10. 10.
    Have you referred patients to the toll-free number 1-877-776-7711 or the ClarusMD CLEARMD Program Website for more information about birth control or for counselling?
  11. 11.
    Which of the following is an important identified risk of ClarusMD?
Submit